Cardiac rhythm management devices continue to evolve rapidly in form factor, reliability and lifespan. Even as implantable designs become increasingly compact and functional, they are introducing groundbreaking new elements like leadless pacing and integrated fixation concepts for minimally invasive deployment. Cardiac rhythm management devices such as pacemakers, implantable cardiac defibrillators (ICDs) and CRT devices are all getting smaller, smarter and longer-lasting.
Rise in cholesterol levels, hypertension, and excessive smoking lead to high risks of cardiac disorders, resulting in the growing need for cardiovascular therapeutic instruments such as CRT devices. Governments and organizations in many countries implement various initiatives to educate and help people to make medical decisions, increase public awareness, and improve the quality of life. Pacemakers, ICDs, and CRT devices are used to treat arrhythmias and are considered as a standard treatment option in many countries.
North America is expected to have the largest market share for cardiac rhythm management, due to developed healthcare infrastructure, government initiatives, rising number of death due to cardiovascular diseases, and rising incidence of arrhythmias demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations are attributed atrial fibrillation. Also, it highlighted that a large part of the American population suffers from atrial fibrillation. Therefore, it is expected to rise further in the forecast period. Asia-Pacific is another region with high potential for this market, due to rising healthcare expenditure by government, increasing the prevalence of cardiac disorders, and growing per capita income of population in South Asian countries.
The global Cardiac Rhythm Management Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Rhythm Management Devices market based on company, product type, end user and key regions.
This report studies the global market size of Cardiac Rhythm Management Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Rhythm Management Devices in these regions.
This research report categorizes the global Cardiac Rhythm Management Devices market by top players/brands, region, type and end user. This report also studies the global Cardiac Rhythm Management Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
St. Jude Medical
Altera
Biotronik
Market size by Product
Implantable Defibrillators
Bi Ventricular Pacemakers
Market size by End User
Hospitals
Clinics
Home Settings
ASCs
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cardiac Rhythm Management Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiac Rhythm Management Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiac Rhythm Management Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiac Rhythm Management Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cardiac Rhythm Management Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Rhythm Management Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Cardiac Rhythm Management Devices. Industry analysis & Market Report on Cardiac Rhythm Management Devices is a syndicated market report, published as Global Cardiac Rhythm Management Devices Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cardiac Rhythm Management Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.